SEARCH RESULTS FOR:

Mining
Senegal
MACIG

Francois Godin

CEO, GRANDE CÔTE OPERATIONS
GCO speaks to GBR about its mineral sands operation in Senegal.
Aerospace
France

The Research Tax Credit Scheme: Spurring on Innovation in the Auvergne-Rhône-Alpes Region

The French government offers a generous tax credit scheme to encourage R&D.
Aerospace
France

Patrick Besnier

PRESIDENT, DBC
DBC speaks to GBR about the business environment in the Auvergne-Rhône-Alpes aero-space sector.
Aerospace
France

Auvergne-Rhône-Alpes Aerospace 2018

Mining
Senegal
MACIG

Mouhamed Kebe, Mohamed Abdallah Dieng & Ismael Itoua

MANAGING PARTNER, ATTORNEY & COUNSEL, GENI & KÉBÉ
GBR speaks to Geni & Kébé about how the law firm can serve investors in West African mining.
Mining
Peru

Peru Mining 2018 E&MJ Release

Petrochemicals & Chemicals
Singapore

Singapore’s Chemical Producers: Feeding Asia’s Appetite

Singapore Chemicals 2018
Singapore’s forward-oriented leadership knows all too well that the city-state will not be able to compete with its neighbors as a low-cost destination for manufacturers.
Pharma & Life Sciences
China

R&D: Is Innovation Really Happening in China?

With an ever-increasing stockpile of innovative technologies and a growing network of talented scientists intently focused on innovation, it will merely be a matter of time before China begins to produce some of the most cutting-edge drugs.
Petrochemicals & Chemicals
Singapore

Manpower Constraints a Persistent Burden for Industry in Singapore

Singapore Chemicals 2018
As the city-state continues its relentless pursuit towards an ecosystem of utopian standards, Industry 4.0 will take it on a new course. This evolution will demand economic, social, and educational change.
Petrochemicals & Chemicals
Singapore

Gary Chan

MANAGING DIRECTOR ASIA PACIFIC, BDP INTERNATIONAL
Singapore Chemicals 2018
BDP in Singapore explains to GBR how it is levering technology to improve service.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL